We observed the predictive power of the TR-DDR score was not significantly higher than the pre-existing predictors, like the tumor-infiltrating lymphocytes (TILs), as well as numerous factors that independently predict clinical response, including PDL1 expression, immune cell exhaustion, and disordered expression levels of cytokines (60, 61). The gene discussed is CD274; the disease is neoplasm.